Literature DB >> 20113956

Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility.

C M Howles1, V Alam, D Tredway, R Homburg, D W Warne.   

Abstract

To identify baseline characteristics related to successful ovulation induction, data were analysed from oligo- or anovulatory patients undergoing their first cycle of human recombinant FSH (r-hFSH; follitropin alfa) in a chronic low-dose (75 IU starting dose), step-up protocol in two clinical trials (n=446). Patients were grouped according to response: group A, ovulated within 14 days (75 IU follitropin alfa); group B, ovulated after 14 days (>75 IU follitropin alfa); group C, not administered human chorionic gonadotrophin (HCG) because of poor response; group D, cycle cancelled due to over-response (HCG not administered); group E, spontaneous ovulation prior to obtaining criteria for administration of HCG. Mean body mass index (BMI) of group A (25.0 kg/m(2)) was significantly lower than groups B (27.1 kg/m(2), P<0.001) or C (28.2 kg/m(2), P<0.0001), but similar to group D (24.3 kg/m(2)). Mean antral follicle count (AFC) of group A was also significantly lower than group C (18.3 versus 22.7; P=0.018), but not significantly different from groups B (21.5) or D (19.5); group E had the highest mean AFC (35.7). Comparatively low BMI, low AFC and higher (although still within the normal range) FSH concentration at baseline were associated with successful ovulation induction in infertile women undergoing a chronic low-dose, step-up stimulation protocol. 2009 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20113956     DOI: 10.1016/j.rbmo.2009.11.017

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  5 in total

1.  Changes in receptivity epithelial cell markers of endometrium after ovarian stimulation treatments: its role during implantation window.

Authors:  Francisco J Valdez-Morales; Armando Gamboa-Domínguez; Victor S Vital-Reyes; Juan C Hinojosa Cruz; Jesús Chimal-Monroy; Yanira Franco-Murillo; Marco Cerbón
Journal:  Reprod Health       Date:  2015-05-17       Impact factor: 3.223

2.  Lipid Metabolic Disorders and Ovarian Hyperstimulation Syndrome: A Retrospective Analysis.

Authors:  Feifei Liu; Qi Jiang; Xuedong Sun; Yuzhen Huang; Zhenzhen Zhang; Ting Han; Yuhua Shi
Journal:  Front Physiol       Date:  2020-11-19       Impact factor: 4.566

3.  Fertility treatment and breast-cancer incidence: meta-analysis.

Authors:  Carolyn Cullinane; Hannah Gillan; James Geraghty; Denis Evoy; Jane Rothwell; Damian McCartan; Enda W McDermott; Ruth S Prichard
Journal:  BJS Open       Date:  2022-01-06

4.  Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction.

Authors:  Gamal I Serour; Mohamed Aboulghar; Awatef Al Bahar; Jean-Noel Hugues; Khaled Esmat
Journal:  Reprod Biol Endocrinol       Date:  2014-06-18       Impact factor: 5.211

Review 5.  Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management.

Authors:  Bahia Namavar Jahromi; Mohammad Ebrahim Parsanezhad; Zahra Shomali; Pardis Bakhshai; Mahshid Alborzi; Najmeh Moin Vaziri; Zahra Anvar
Journal:  Iran J Med Sci       Date:  2018-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.